BioPlus Acquisition Corp – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 06/30/23 Q2

ended 03/31/23 Q1

ended 12/31/22 FY 2022

ended 09/30/22 Q3

ended 06/30/22 Q2

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Registration withdrawal request

Business combination disclosure

Business combination disclosure

Ownership Filter

Cantor Fitzgerald Securities

Polar Asset Management Partners Inc.

Saba Capital Management, L.P.

Highbridge Capital Management LLC

BioPlus Sponsor LLC

News Filter

Announces Termination of Business Combination Agreement With Avertix Medical, Inc. and Its Intention to Liquidate

Investor Presentation

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Unregistered Sales of Equity Securities, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Investor Presentation

Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger With BIOS Acquisition Corporation

Proxies Filter

Definitive proxy

Preliminary proxy

Other Filter

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness